MRA Associates USA’s Pfizer PFE Stock Holding History

MRA Associates USA’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-582	Closed	-$23.9K	–	147
2019 Q2	$23.9K	Buy	+582	New	+$23.1K	0.09%	86

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

MRA Associates USA's PFE Position: Q3 2019 in Review

MRA Associates USA sold out of Pfizer (PFE) in Q3 2019, closing a stake of 582 shares — an estimated $23.9K sold.

MRA Associates USA first reported a position in PFE in Q2 2019 and held it in 1 quarter. The position peaked at $23.9K in Q2 2019. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.

MRA Associates USA reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
MRA Associates USA sold 582 Pfizer shares in Q3 2019, an estimated $23.9K.
MRA Associates USA first reported a position in Pfizer in Q2 2019 and held it in 1 quarter.
MRA Associates USA's Pfizer position peaked at $23.9K in Q2 2019.
2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.

Based on MRA Associates USA's 13F filing for Q3 2019, filed 8 Nov 2019.